A Comparative Study on Efficacy and Safety of Propofol versus Dexmedetomidine in Sleep Apnea Patients undergoing Drug-Induced Sleep Endoscopy: A CONSORT-Prospective, Randomized, Controlled Clinical Trial

L L Zhao, H Liu, Y Y Zhang, J Q Wei, Y Han, L Han, J P Yang, L L Zhao, H Liu, Y Y Zhang, J Q Wei, Y Han, L Han, J P Yang

Abstract

The aim of this study is to compare the efficacy and safety of propofol with dexmedetomidine in patients with obstructive sleep apnea hypopnea syndrome (SAHS) undergoing drug-induced sleep endoscopy (DISE). The 88 patients diagnosed with SAHS in the Affiliated Hospital of Xuzhou Medical University were randomly allocated into 2 groups (n = 44). Patients in the group dexmedetomidine (group D) received continuous intravenous infusion of dexmedetomidine 1 μg/kg over 15 minutes before the endoscopy, and propofol 2 mg/kg was intravenously administrated in the group propofol (group P). Cardiopulmonary parameters of patients were recorded. The time to fall asleep, duration of endoscopic examination, the wakeup time of patients, the number of mask ventilations for patients, the satisfaction of patients and endoscopic performers, and false positive cases of SAHS of patients were compared between the two groups. Compared with group D, mean arterial pressure (MAP) and blood oxygen saturation (SPO2) of patients in the P group were lower at the time point of T1 (P < 0.05), the duration of endoscopic examination and wakeup time of patients were obviously prolonged, the incidence of mask ventilation for patients and false positive cases of SAHS of patients was observably higher, and the satisfaction of endoscopic performers was markedly lower, but the time to fall asleep was significantly shortened (P < 0.05). Dexmedetomidine served as a novel sleep induced drug and can provide satisfactory conditions and be safely and effectively applied for endoscopy in patients with SAHS, without adverse hemodynamic effects.

Figures

Figure 1
Figure 1
CONSORT flow diagram of patients included in the study.

References

    1. Vianello A., Bisogni V., Rinaldo C., et al. Recent advances in the diagnosis and management of obstructive sleep apnea. Minerva Medica. 2016;107(6):437–451.
    1. Shteamer J. W., Dedhia R. C. Sedative choice in drug-induced sleep endoscopy: A neuropharmacology-based review. The Laryngoscope. 2017;127(1):273–279. doi: 10.1002/lary.26132.
    1. Cho J. S., Soh S., Kim E. J., et al. Comparison of three sedation regimens for drug-induced sleep endoscopy. Sleep and Breathing. 2015;19(2):711–717. doi: 10.1007/s11325-015-1127-9.
    1. Anand S., Bhatia A., Kumar R., Sapra H., Gupta V., Mehta Y. Dexmedetomidine for monitored anesthesia care in patients undergoing liberation procedure for multiple sclerosis: An observational study. Saudi Journal of Anaesthesia. 2012;6(4):358–362. doi: 10.4103/1658-354X.105865.
    1. Cao J.-L., Pei Y.-P., Wei J.-Q., Zhang Y.-Y. Effects of intraoperative dexmedetomidine with intravenous anesthesia on postoperative emergence agitation/delirium in pediatric patients undergoing tonsillectomy with or without adenoidectomy: A CONSORT-prospective, randomized, controlled clinical trial. Medicine (United States) 2016;95(49):p. e5566. doi: 10.1097/MD.0000000000005566.
    1. Tuffaha H. W., Reynolds H., Gordon L. G., Rickard C. M., Scuffham P. A. Value of information analysis optimizing future trial design from a pilot study on catheter securement devices. Clinical Trials. 2014;11(6):648–656. doi: 10.1177/1740774514545634.
    1. Charan J., Biswas T. How to calculate sample size for different study designs in medical research? Indian Journal of Psychological Medicine. 2013;35(2):121–126. doi: 10.4103/0253-7176.116232.
    1. Hwang W., Lee J., Park J., Joo J. Dexmedetomidine versus remifentanil in postoperative pain control after spinal surgery: A randomized controlled study. BMC Anesthesiology. 2015;15(1)
    1. Ge D.-J., Qi B., Tang G., Li J.-Y. Intraoperative dexmedetomidine promotes postoperative analgesia and recovery in patients after abdominal colectomy: A CONSORT-prospective, randomized, controlled clinical trial. Medicine (United States) 2015;94(43) doi: 10.1097/MD.0000000000001727.e1727
    1. Gagnadoux F., Priou P., Urban T., Meslier N., Trzepizur W. Sleep apneas, metabolic syndrome and cardiovascular risk: Data from the Pays de la Loire sleep cohort. Revue de Pneumologie Clinique. 2017;73(6):299–305. doi: 10.1016/j.pneumo.2017.09.001.
    1. Zhao Y., Yu B. Y., Liu Y., Liu Y. Meta-Analysis of the Effect of Obstructive Sleep Apnea on Cardiovascular Events After Percutaneous Coronary Intervention. American Journal of Cardiology. 2017;120(6):1026–1030. doi: 10.1016/j.amjcard.2017.06.035.
    1. Anttalainen U., Tenhunen M., Rimpilä V., et al. Prolonged partial upper airway obstruction during sleep – an underdiagnosed phenotype of sleep-disordered breathing. European Clinical Respiratory Journal. 2016;3(1):p. 31806. doi: 10.3402/ecrj.v3.31806.
    1. Bosi M., De Vito A., Gobbi R., Poletti V., Vicini C. The importance of obstructive sleep apnoea and hypopnea pathophysiology for customized therapy. European Archives of Oto-Rhino-Laryngology. 2017;274(3):1251–1261. doi: 10.1007/s00405-016-4223-y.
    1. Rezaeitalab F., Moharrari F., Saberi S., Asadpour H., Rezaeetalab F. The correlation of anxiety and depression with obstructive sleep apnea syndrome. Journal of Research in Medical Sciences. 2014;19(3):205–210.
    1. Lin H., Weaver E. M., Lin H., Friedman M. Sleep-Related Breathing Disorders. Vol. 80. S. Karger AG; 2017. Multilevel Obstructive Sleep Apnea Surgery; pp. 109–115. (Advances in Oto-Rhino-Laryngology).
    1. Camacho M., Certal V., Capasso R. Comprehensive review of surgeries for obstructive sleep apnea syndrome. Brazilian Journal of Otorhinolaryngology. 2013;79(6):780–788. doi: 10.5935/1808-8694.20130139.
    1. Caples S. M., Rowley J. A., Prinsell J. R., et al. Surgical modifications of the upper airway for obstructive sleep apnea in adults: a systematic review and meta-analysis. SLEEP. 2010;33(10):1396–1407. doi: 10.1093/sleep/33.10.1396.
    1. Croft C. B., Pringle M. Sleep nasendoscopy: a technique of assessment in snoring and obstructive sleep apnoea. Clinical Otolaryngology & Allied Sciences. 1991;16(5):504–509. doi: 10.1111/j.1365-2273.1991.tb02103.x.
    1. Attri J., Sharan R., Makkar V., Gupta K., Khetarpal R., Kataria A. Conscious sedation: Emerging trends in pediatric dentistry. Anesthesia: Essays and Researches. 2017;11(2):p. 277. doi: 10.4103/0259-1162.171458.
    1. Khurmi N., Patel P., Kraus M., Trentman T. Pharmacologic Considerations for Pediatric Sedation and Anesthesia Outside the Operating Room: A Review for Anesthesia and Non-Anesthesia Providers. Pediatric Drugs. 2017;19(5):435–446. doi: 10.1007/s40272-017-0241-5.
    1. King C. H., Beutler S. S., Kaye A. D., Urman R. D. Pharmacologic Properties of Novel Local Anesthetic Agents in Anesthesia Practice. Anesthesiology Clinics. 2017;35(2):315–325. doi: 10.1016/j.anclin.2017.01.019.
    1. Nguyen V., Tiemann D., Park E., Salehi A. Alpha-2 Agonists. Anesthesiology Clinics. 2017;35(2):233–245. doi: 10.1016/j.anclin.2017.01.009.
    1. Sanders R. D., Maze M. Alpha2-adrenoceptor agonists. Current Opinion in Investigational Drugs. 2007;8:25–33.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi